乙型肝炎

StephenW

乙型肝炎



每年，全世界有超过 800,000 人死于与乙型肝炎相关的肝病——这比疟疾造成的死亡人数还要多。遏制传播和开发消除病毒的药物的努力正在加速全球根除该疾病的努力。本《自然展望》探讨：

    一系列药物的开发，通过正确的组合，可以使数百万人摆脱肝炎。

    乙型肝炎——通常与肥胖、脂肪肝疾病和某些肠道微生物群一起发生——如何增加患肝癌的风险。

    世界许多地方对这种情况的污名化——以及患者如何找到声音来抵制并要求结束歧视和孤立。

    努力阻止疾病从受感染的母亲传播给新生儿。

    为什么，尽管有一些成功的故事，但全球抗击乙型肝炎的斗争进展不均衡——世界低收入地区却成了短线。

    乙型肝炎在撒哈拉以南非洲普遍存在，但许多国家缺乏提高认识和治疗患者的资源。

    为什么澳大利亚原住民的乙型肝炎患病率如此之高。


阅读更多 - 立即访问您的免费自然展望 »

StephenW

Hepatitis B
         


Every year, more than 800,000 people worldwide die from hepatitis-B-related liver disease — a greater toll than from malaria. Efforts to curb transmission and develop drugs that eliminate the virus are picking up steam in a global effort to eradicate the disease. This Nature Outlook explores:

    The development of an array of drugs that could, in the right combination, liberate millions of people from hepatitis.

    How hepatitis B — often acting alongside obesity, fatty liver disease and certain gut microbiota — raises the risk of liver cancer.

    The stigmatization of the condition in many parts of the world — and how patients are finding a voice to push back and demand an end to discrimination and isolation.

    The effort to stop the spread of the disease from infected mothers to their newborns.

    Why, despite some success stories, the global fight against hepatitis B is making uneven progress — with the lower-income parts of the world getting the short straw.

    Hepatitis B is widespread in sub-Saharan Africa, but many countries lack the resources to heighten awareness and treat patients.

    Why Indigenous people in Australia have such a high prevalence of hepatitis B.


Read more – access your free Nature Outlook today »

StephenW

https://www.nature.com/collectio ... 1A5FDE5F1F51E020AC7